[HTML] springer.comFull View

[HTML][HTML] CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

KM Maalej, M Merhi, VP Inchakalody, S Mestiri… - Molecular Cancer, 2023 - Springer
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …
被引用次数：121 相关文章
[PDF] academia.edu

[PDF][PDF] CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

KM Maalej, M Merhi, VP Inchakalody, S Mestiri, M Alam… - 2023 - academia.edu
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …
[HTML] nih.gov

[HTML][HTML] CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

KM Maalej, M Merhi, VP Inchakalody, S Mestiri… - Molecular …, 2023 - ncbi.nlm.nih.gov
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances.

KM Maalej, M Merhi, VP Inchakalody… - Molecular …, 2023 - search.ebscohost.com
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …
[HTML] biomedcentral.com

[HTML][HTML] CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

KM Maalej, M Merhi… - Molecular …, 2023 - molecular-cancer.biomedcentral …
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

K Maalej, M Merhi, V Inchakalody, S Mestiri… - Molecular …, 2023 - europepmc.org
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

KM Maalej, M Merhi, VP Inchakalody… - Molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

KM Maalej, M Merhi, VP Inchakalody… - Molecular …, 2023 - search.proquest.com
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances.

KM Maalej, M Merhi, VP Inchakalody… - Molecular …, 2023 - search.ebscohost.com
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …
[PDF] biomedcentral.com

[PDF][PDF] CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

KM Maalej, M Merhi, VP Inchakalody, S Mestiri… - 2023 - molecular-cancer.biomedcentral …
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …